0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Yellow Fever Vaccines Market Research Report 2026
Published Date: 2026-04-13
|
Report Code: QYRE-Auto-19N9092
Home | Market Reports
Global Yellow Fever Vaccines Market Outlook 2022
BUY CHAPTERS

Global Yellow Fever Vaccines Market Research Report 2026

Code: QYRE-Auto-19N9092
Report
2026-04-13
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Yellow Fever Vaccines Market Size

The global Yellow Fever Vaccines market was valued at US$ 145 million in 2025 and is anticipated to reach US$ 193 million by 2032, at a CAGR of 4.2% from 2026 to 2032.

Yellow Fever Vaccines Market

Yellow Fever Vaccines Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Yellow Fever Vaccines competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Yellow fever vaccine is a vaccine that can prevent yellow fever. The vaccination targets are people who enter or pass through the epidemic area.
The global Yellow Fever Vaccines market is primarily driven by the increasing risk of yellow fever outbreaks, particularly in endemic regions such as sub-Saharan Africa and parts of South America. Growing international travel and global mobility have heightened the need for preventive vaccination, especially in travelers visiting high-risk areas. Government-led immunization programs and World Health Organization (WHO) initiatives, such as the Eliminate Yellow Fever Epidemics (EYE) strategy, also contribute to increased vaccine demand. Moreover, rising public health awareness and emergency stockpiling by international health agencies are enhancing market growth, with mass vaccination campaigns being conducted to prevent potential epidemics.
Despite the demand, the Yellow Fever Vaccines market faces several significant challenges. Limited global manufacturing capacity can lead to supply shortages during epidemic surges, causing delays in immunization programs. The vaccine requires cold chain logistics and must be stored at controlled temperatures, which poses distribution challenges in low-resource settings. Additionally, adverse reactions to the live-attenuated vaccine—though rare—can affect public perception and vaccination uptake. Regulatory hurdles and the long timeline for clinical trials and approval of newer formulations or alternatives also slow down market expansion, especially as newer manufacturers attempt to enter the space.
Emerging trends in the Yellow Fever Vaccines market include increased public-private partnerships to scale up vaccine production and improve distribution infrastructure. Technological advancements are pushing toward the development of thermostable formulations to overcome cold chain barriers. There is also rising investment in regional vaccine manufacturing hubs, particularly in Africa, to reduce reliance on global supply chains. Enhanced surveillance systems, digital vaccination records, and integration of yellow fever vaccines into routine immunization schedules are improving coverage rates. Moreover, the expansion of travel-related vaccine requirements and efforts to ensure universal access in endemic regions are expected to drive long-term market growth.
Global Yellow Fever Vaccines key players include Sanofi Pasteur, Bio-Manguinhos, FSUE Chumakov, etc. Global top three manufacturers hold a share about 90%. Middle East and Africa is the largest market, with a share about 70%, followed by South America, and Europe, both have a share about 30 percent. In terms of application, the largest application is Routine Immunization, followed by Travelers.
This report delivers a comprehensive overview of the global Yellow Fever Vaccines market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Yellow Fever Vaccines. The Yellow Fever Vaccines market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Yellow Fever Vaccines market comprehensively. Regional market sizes by Distribution Channel, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Yellow Fever Vaccines manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Distribution Channel, by Application, and by region.
Market Segmentation

Scope of Yellow Fever Vaccines Market Report

Report Metric Details
Report Name Yellow Fever Vaccines Market
Accounted market size in 2025 US$ 145 million
Forecasted market size in 2032 US$ 193 million
CAGR 4.2%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Distribution Channel
  • Institonal Contributions
  • Private Purchase
  • Others
by Application
  • Routine Immunization
  • Travelers
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi Pasteur, Bio-Manguinhos, FSUE Chumakov, Institut Pasteur de Dakar
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Distribution Channel, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Yellow Fever Vaccines manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Yellow Fever Vaccines sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Distribution Channel, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Yellow Fever Vaccines Market growing?

Ans: The Yellow Fever Vaccines Market witnessing a CAGR of 4.2% during the forecast period 2026-2032.

What is the Yellow Fever Vaccines Market size in 2032?

Ans: The Yellow Fever Vaccines Market size in 2032 will be US$ 193 million.

What is the market share of major companies in Yellow Fever Vaccines Market?

Ans: Global top three manufacturers hold a share about 90%.

Who are the main players in the Yellow Fever Vaccines Market report?

Ans: The main players in the Yellow Fever Vaccines Market are Sanofi Pasteur, Bio-Manguinhos, FSUE Chumakov, Institut Pasteur de Dakar

What are the Application segmentation covered in the Yellow Fever Vaccines Market report?

Ans: The Applications covered in the Yellow Fever Vaccines Market report are Routine Immunization, Travelers, Other

1 Yellow Fever Vaccines Market Overview
1.1 Product Definition
1.2 Yellow Fever Vaccines by Distribution Channel
1.2.1 Global Yellow Fever Vaccines Market Value by Distribution Channel: 2025 vs 2032
1.2.2 Institonal Contributions
1.2.3 Private Purchase
1.2.4 Others
1.3 Yellow Fever Vaccines by Application
1.3.1 Global Yellow Fever Vaccines Market Value by Application: 2025 vs 2032
1.3.2 Routine Immunization
1.3.3 Travelers
1.3.4 Other
1.4 Global Yellow Fever Vaccines Market Size Estimates and Forecasts
1.4.1 Global Yellow Fever Vaccines Revenue 2021–2032
1.4.2 Global Yellow Fever Vaccines Sales 2021–2032
1.4.3 Global Yellow Fever Vaccines Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Yellow Fever Vaccines Market Competition by Manufacturers
2.1 Global Yellow Fever Vaccines Sales Market Share by Manufacturers (2021–2026)
2.2 Global Yellow Fever Vaccines Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Yellow Fever Vaccines Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Yellow Fever Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Yellow Fever Vaccines, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Yellow Fever Vaccines, Product Types and Applications
2.7 Global Key Manufacturers of Yellow Fever Vaccines, Date of Entry into the Industry
2.8 Global Yellow Fever Vaccines Market Competitive Situation and Trends
2.8.1 Global Yellow Fever Vaccines Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Yellow Fever Vaccines Players Market Share by Revenue
2.8.3 Global Yellow Fever Vaccines Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Yellow Fever Vaccines Market Scenario by Region
3.1 Global Yellow Fever Vaccines Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Yellow Fever Vaccines Sales by Region: 2021–2032
3.2.1 Global Yellow Fever Vaccines Sales by Region: 2021–2026
3.2.2 Global Yellow Fever Vaccines Sales by Region: 2027–2032
3.3 Global Yellow Fever Vaccines Revenue by Region: 2021–2032
3.3.1 Global Yellow Fever Vaccines Revenue by Region: 2021–2026
3.3.2 Global Yellow Fever Vaccines Revenue by Region: 2027–2032
3.4 North America Yellow Fever Vaccines Market Facts & Figures by Country
3.4.1 North America Yellow Fever Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Yellow Fever Vaccines Sales by Country (2021–2032)
3.4.3 North America Yellow Fever Vaccines Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Yellow Fever Vaccines Market Facts & Figures by Country
3.5.1 Europe Yellow Fever Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Yellow Fever Vaccines Sales by Country (2021–2032)
3.5.3 Europe Yellow Fever Vaccines Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Yellow Fever Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Yellow Fever Vaccines Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Yellow Fever Vaccines Sales by Region (2021–2032)
3.6.3 Asia Pacific Yellow Fever Vaccines Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Yellow Fever Vaccines Market Facts & Figures by Country
3.7.1 Latin America Yellow Fever Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Yellow Fever Vaccines Sales by Country (2021–2032)
3.7.3 Latin America Yellow Fever Vaccines Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Yellow Fever Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Yellow Fever Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Yellow Fever Vaccines Sales by Country (2021–2032)
3.8.3 Middle East and Africa Yellow Fever Vaccines Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Distribution Channel
4.1 Global Yellow Fever Vaccines Sales by Distribution Channel (2021–2032)
4.1.1 Global Yellow Fever Vaccines Sales by Distribution Channel (2021–2026)
4.1.2 Global Yellow Fever Vaccines Sales by Distribution Channel (2027–2032)
4.1.3 Global Yellow Fever Vaccines Sales Market Share by Distribution Channel (2021–2032)
4.2 Global Yellow Fever Vaccines Revenue by Distribution Channel (2021–2032)
4.2.1 Global Yellow Fever Vaccines Revenue by Distribution Channel (2021–2026)
4.2.2 Global Yellow Fever Vaccines Revenue by Distribution Channel (2027–2032)
4.2.3 Global Yellow Fever Vaccines Revenue Market Share by Distribution Channel (2021–2032)
4.3 Global Yellow Fever Vaccines Price by Distribution Channel (2021–2032)
5 Segment by Application
5.1 Global Yellow Fever Vaccines Sales by Application (2021–2032)
5.1.1 Global Yellow Fever Vaccines Sales by Application (2021–2026)
5.1.2 Global Yellow Fever Vaccines Sales by Application (2027–2032)
5.1.3 Global Yellow Fever Vaccines Sales Market Share by Application (2021–2032)
5.2 Global Yellow Fever Vaccines Revenue by Application (2021–2032)
5.2.1 Global Yellow Fever Vaccines Revenue by Application (2021–2026)
5.2.2 Global Yellow Fever Vaccines Revenue by Application (2027–2032)
5.2.3 Global Yellow Fever Vaccines Revenue Market Share by Application (2021–2032)
5.3 Global Yellow Fever Vaccines Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Company Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur Yellow Fever Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Sanofi Pasteur Yellow Fever Vaccines Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 Bio-Manguinhos
6.2.1 Bio-Manguinhos Company Information
6.2.2 Bio-Manguinhos Description and Business Overview
6.2.3 Bio-Manguinhos Yellow Fever Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Bio-Manguinhos Yellow Fever Vaccines Product Portfolio
6.2.5 Bio-Manguinhos Recent Developments/Updates
6.3 FSUE Chumakov
6.3.1 FSUE Chumakov Company Information
6.3.2 FSUE Chumakov Description and Business Overview
6.3.3 FSUE Chumakov Yellow Fever Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 FSUE Chumakov Yellow Fever Vaccines Product Portfolio
6.3.5 FSUE Chumakov Recent Developments/Updates
6.4 Institut Pasteur de Dakar
6.4.1 Institut Pasteur de Dakar Company Information
6.4.2 Institut Pasteur de Dakar Description and Business Overview
6.4.3 Institut Pasteur de Dakar Yellow Fever Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Institut Pasteur de Dakar Yellow Fever Vaccines Product Portfolio
6.4.5 Institut Pasteur de Dakar Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Yellow Fever Vaccines Industry Chain Analysis
7.2 Yellow Fever Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Yellow Fever Vaccines Production Mode & Process Analysis
7.4 Yellow Fever Vaccines Sales and Marketing
7.4.1 Yellow Fever Vaccines Sales Channels
7.4.2 Yellow Fever Vaccines Distributors
7.5 Yellow Fever Vaccines Customer Analysis
8 Yellow Fever Vaccines Market Dynamics
8.1 Yellow Fever Vaccines Industry Trends
8.2 Yellow Fever Vaccines Market Drivers
8.3 Yellow Fever Vaccines Market Challenges
8.4 Yellow Fever Vaccines Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Yellow Fever Vaccines Market Value by Distribution Channel (US$ Million), 2025 vs 2032
 Table 2. Global Yellow Fever Vaccines Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Yellow Fever Vaccines Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Yellow Fever Vaccines Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Yellow Fever Vaccines Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Yellow Fever Vaccines Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Yellow Fever Vaccines Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Yellow Fever Vaccines Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Yellow Fever Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Yellow Fever Vaccines, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Yellow Fever Vaccines, Product Types and Applications
 Table 12. Global Key Manufacturers of Yellow Fever Vaccines, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Yellow Fever Vaccines Companies by Tier (Tier 1, Tier 2, Tier 3), based on Yellow Fever Vaccines Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Yellow Fever Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Yellow Fever Vaccines Sales by Region (K Units), 2021–2026
 Table 18. Global Yellow Fever Vaccines Sales Market Share by Region (2021–2026)
 Table 19. Global Yellow Fever Vaccines Sales by Region (K Units), 2027–2032
 Table 20. Global Yellow Fever Vaccines Sales Market Share by Region (2027–2032)
 Table 21. Global Yellow Fever Vaccines Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Yellow Fever Vaccines Revenue Market Share by Region (2021–2026)
 Table 23. Global Yellow Fever Vaccines Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Yellow Fever Vaccines Revenue Market Share by Region (2027–2032)
 Table 25. North America Yellow Fever Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Yellow Fever Vaccines Sales by Country (K Units), 2021–2026
 Table 27. North America Yellow Fever Vaccines Sales by Country (K Units), 2027–2032
 Table 28. North America Yellow Fever Vaccines Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Yellow Fever Vaccines Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Yellow Fever Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Yellow Fever Vaccines Sales by Country (K Units), 2021–2026
 Table 32. Europe Yellow Fever Vaccines Sales by Country (K Units), 2027–2032
 Table 33. Europe Yellow Fever Vaccines Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Yellow Fever Vaccines Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Yellow Fever Vaccines Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Yellow Fever Vaccines Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Yellow Fever Vaccines Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Yellow Fever Vaccines Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Yellow Fever Vaccines Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Yellow Fever Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Yellow Fever Vaccines Sales by Country (K Units), 2021–2026
 Table 42. Latin America Yellow Fever Vaccines Sales by Country (K Units), 2027–2032
 Table 43. Latin America Yellow Fever Vaccines Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Yellow Fever Vaccines Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Yellow Fever Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Yellow Fever Vaccines Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Yellow Fever Vaccines Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Yellow Fever Vaccines Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Yellow Fever Vaccines Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Yellow Fever Vaccines Sales (K Units) by Distribution Channel (2021–2026)
 Table 51. Global Yellow Fever Vaccines Sales (K Units) by Distribution Channel (2027–2032)
 Table 52. Global Yellow Fever Vaccines Sales Market Share by Distribution Channel (2021–2026)
 Table 53. Global Yellow Fever Vaccines Sales Market Share by Distribution Channel (2027–2032)
 Table 54. Global Yellow Fever Vaccines Revenue (US$ Million) by Distribution Channel (2021–2026)
 Table 55. Global Yellow Fever Vaccines Revenue (US$ Million) by Distribution Channel (2027–2032)
 Table 56. Global Yellow Fever Vaccines Revenue Market Share by Distribution Channel (2021–2026)
 Table 57. Global Yellow Fever Vaccines Revenue Market Share by Distribution Channel (2027–2032)
 Table 58. Global Yellow Fever Vaccines Price (US$/Unit) by Distribution Channel (2021–2026)
 Table 59. Global Yellow Fever Vaccines Price (US$/Unit) by Distribution Channel (2027–2032)
 Table 60. Global Yellow Fever Vaccines Sales (K Units) by Application (2021–2026)
 Table 61. Global Yellow Fever Vaccines Sales (K Units) by Application (2027–2032)
 Table 62. Global Yellow Fever Vaccines Sales Market Share by Application (2021–2026)
 Table 63. Global Yellow Fever Vaccines Sales Market Share by Application (2027–2032)
 Table 64. Global Yellow Fever Vaccines Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Yellow Fever Vaccines Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Yellow Fever Vaccines Revenue Market Share by Application (2021–2026)
 Table 67. Global Yellow Fever Vaccines Revenue Market Share by Application (2027–2032)
 Table 68. Global Yellow Fever Vaccines Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Yellow Fever Vaccines Price (US$/Unit) by Application (2027–2032)
 Table 70. Sanofi Pasteur Company Information
 Table 71. Sanofi Pasteur Description and Business Overview
 Table 72. Sanofi Pasteur Yellow Fever Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Sanofi Pasteur Yellow Fever Vaccines Product
 Table 74. Sanofi Pasteur Recent Developments/Updates
 Table 75. Bio-Manguinhos Company Information
 Table 76. Bio-Manguinhos Description and Business Overview
 Table 77. Bio-Manguinhos Yellow Fever Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Bio-Manguinhos Yellow Fever Vaccines Product
 Table 79. Bio-Manguinhos Recent Developments/Updates
 Table 80. FSUE Chumakov Company Information
 Table 81. FSUE Chumakov Description and Business Overview
 Table 82. FSUE Chumakov Yellow Fever Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. FSUE Chumakov Yellow Fever Vaccines Product
 Table 84. FSUE Chumakov Recent Developments/Updates
 Table 85. Institut Pasteur de Dakar Company Information
 Table 86. Institut Pasteur de Dakar Description and Business Overview
 Table 87. Institut Pasteur de Dakar Yellow Fever Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Institut Pasteur de Dakar Yellow Fever Vaccines Product
 Table 89. Institut Pasteur de Dakar Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. Yellow Fever Vaccines Distributors List
 Table 93. Yellow Fever Vaccines Customers List
 Table 94. Yellow Fever Vaccines Market Trends
 Table 95. Yellow Fever Vaccines Market Drivers
 Table 96. Yellow Fever Vaccines Market Challenges
 Table 97. Yellow Fever Vaccines Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Yellow Fever Vaccines
 Figure 2. Global Yellow Fever Vaccines Market Value by Distribution Channel (US$ Million), 2021–2032
 Figure 3. Global Yellow Fever Vaccines Market Share by Distribution Channel: 2025 & 2032
 Figure 4. Institonal Contributions Product Picture
 Figure 5. Private Purchase Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Yellow Fever Vaccines Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Yellow Fever Vaccines Market Share by Application: 2025 & 2032
 Figure 9. Routine Immunization
 Figure 10. Travelers
 Figure 11. Other
 Figure 12. Global Yellow Fever Vaccines Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Yellow Fever Vaccines Market Size (US$ Million), 2021–2032
 Figure 14. Global Yellow Fever Vaccines Sales (K Units), 2021–2032
 Figure 15. Global Yellow Fever Vaccines Average Price (US$/Unit), 2021–2032
 Figure 16. Yellow Fever Vaccines Report Years Considered
 Figure 17. Yellow Fever Vaccines Sales Share by Manufacturers in 2025
 Figure 18. Global Yellow Fever Vaccines Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Yellow Fever Vaccines Players: Market Share by Revenue in Yellow Fever Vaccines in 2025
 Figure 20. Yellow Fever Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Yellow Fever Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Yellow Fever Vaccines Sales Market Share by Country (2021–2032)
 Figure 23. North America Yellow Fever Vaccines Revenue Market Share by Country (2021–2032)
 Figure 24. United States Yellow Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Yellow Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Yellow Fever Vaccines Sales Market Share by Country (2021–2032)
 Figure 27. Europe Yellow Fever Vaccines Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Yellow Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Yellow Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Yellow Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Yellow Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Yellow Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Yellow Fever Vaccines Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Yellow Fever Vaccines Revenue Market Share by Region (2021–2032)
 Figure 35. China Yellow Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Yellow Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Yellow Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Yellow Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Yellow Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Yellow Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Indonesia Yellow Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Thailand Yellow Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Malaysia Yellow Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Yellow Fever Vaccines Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Yellow Fever Vaccines Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Yellow Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Yellow Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Yellow Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Yellow Fever Vaccines Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Yellow Fever Vaccines Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Yellow Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Yellow Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Yellow Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Yellow Fever Vaccines by Distribution Channel (2021–2032)
 Figure 55. Global Revenue Market Share of Yellow Fever Vaccines by Distribution Channel (2021–2032)
 Figure 56. Global Yellow Fever Vaccines Price (US$/Unit) by Distribution Channel (2021–2032)
 Figure 57. Global Sales Market Share of Yellow Fever Vaccines by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Yellow Fever Vaccines by Application (2021–2032)
 Figure 59. Global Yellow Fever Vaccines Price (US$/Unit) by Application (2021–2032)
 Figure 60. Yellow Fever Vaccines Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS